Protected Docs Still In Play In Generic Asacol Spat

Law360, New York (January 24, 2011, 8:23 PM EST) -- A federal judge has overturned the rejection of Medeva Pharma Suisse AG and Warner Chilcott Pharmaceuticals Inc.'s bid to force generic-drug maker Roxane Laboratories Inc. to disclose allegedly confidential documents in their dispute over inflammatory bowel disorder drug Asacol.

Judge Freda L. Wolfson of the U.S. District Court for the District of New Jersey on Monday vacated and remanded a magistrate judge's July 8 order denying the plaintiffs' request for modification of a discovery confidentiality order regarding certain reports and in vivo testing that Roxane has...
To view the full article, register now.